MedPath

Metformin and Core Temperature in Obese and Lean Males

Not Applicable
Completed
Conditions
Obesity
Interventions
Registration Number
NCT02783053
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

Metformin is known to increase 18F-FDG uptake in subjects using metformin in retrospective trials.

In this study the researchers aim to investigate the influence of metformin (500 mg 1/day) on temperature in the colon, glucose uptake in the colon and energy expenditure in healthy lean (BMI \< 24kg/m2) or obese subjects (BMI\>28kg/m2). The investigators will measure 18F-FDG uptake in the colon, temperature in the colon, insulin sensitivity and energy expenditure before after using metformin.

Detailed Description

Obesity and diabetes mellitus type 2 (DM2) are health problems with a tremendous impact. Many attempts have been made to combat obesity and DM2, however, a breakthrough therapy is still lacking.

Obesity is the result of an imbalance between energy intake and energy expenditure. 18F-fluorodeoxy-d-glucose (18F-FDG) positron emission tomography computed tomography (PET-CT) pinpoint areas with high glucose turnover. Physiological 18F-FDG accumulation is frequently observed in the colon. Therefore, the colon might play an important role in increasing energy expenditure by consuming calories. However, the possibility of the colon as an energy dissipating tissue has not yet been explored. The colon could become an interesting new target of research to find a method to combat obesity.

Metformin is one of the few drugs in the treatment of DM2 that is associated with moderate weight loss. Interestingly, patients using metformin show an increased 18F-FDG-uptake in the colon. Whether this higher uptake of glucose also cause an increase in core temperature and/or an increase in energy expenditure is not known. The cause for this increase in glucose uptake in the colon by metformin use is unknown. Also, it is unknown whether this increase in glucose uptake results in an increased energy expenditure and/or an increase in core body temperature.

Objective: In this study the researchers aim to investigate the influence of metformin (500 mg 1/day) on temperature in the colon, glucose uptake in the colon and energy expenditure in healthy lean (BMI \< 24kg/m2) or obese subjects (BMI\>28kg/m2). The investigators will measure 18F-FDG uptake in the colon, temperature in the colon, insulin sensitivity and energy expenditure before after using metformin.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
18
Inclusion Criteria
  • Male
  • Caucasian origin
  • Subjects should be able and willing to give informed consent
  • > 50 years old
  • BMI< 24 kg/m2 or > 28 kg/m2
Read More
Exclusion Criteria
  • Renal failure (GFR< 60ml/min)
  • Liver insufficiency (AST or alanine aminotransferase 3 times upper value)
  • Chronic use of drugs or medication
  • Diabetes mellitus
  • Lactate acidosis or precoma diabeticum in medical history
  • Acute or chronic diseases such as: dehydration, severe infection, shock, heartfailure, pulmonary insufficiency, recent heart attack
  • Alcoholism
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Metformin useMetforminThe investigators compare the use of metformin vs no metformin
Primary Outcome Measures
NameTimeMethod
18F-FDG uptake1 week

Difference in 18F-FDG uptake as registered by 18F-FDG PET-CT before and after 7 days of daily metformin use.

Secondary Outcome Measures
NameTimeMethod
Core temperature using a temperature pill48 hours

- Difference in core body temperature before and after metformin

Correlation core temperature and 18F-FDG uptake1 week

- Correlation between 18F-FDG uptake in the colon and core temperature

Energy expenditure (kcal/day) using ventilated hood30 minutes

- Difference in energy expenditure before and after metformin use

Correlation between 18F-FDG uptake and energy expenditure1 week

- Correlation between difference inenergy expenditure and 18F-FDG uptake in the colon

Trial Locations

Locations (1)

Academic Medical Center

🇳🇱

Amsterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath